salk institute logo

Salk's Cancer Center

Leadership

Salk Institute for Biological Studies - Salk's Cancer Center - Leadership

People

Director


page link:

Reuben Shaw, PhD

Professor

William R. Brody Chair

Areas of interest: metabolic changes and vulnerabilities in cancer, autophagy, starvation signaling

Disease models: lung cancer, pancreatic cancer, hamartoma syndromes

Reuben Shaw, PhD

Deputy Directors


page link:

Susan Kaech, PhD

Professor and Director

NOMIS Chair

Areas of interest: T cell function, tumor immunology

Disease models: immune checkpoint inhibitors in model systems

Susan Kaech
Susan Kaech, PhD
Deputy Director, Research
page link:

Ronald Evans, PhD

Professor and Director

March of Dimes Chair in Molecular and Developmental Biology

Areas of interest: nuclear receptor function in metabolism and cancer

Disease models: pancreatic cancer, colon cancer, diabetes

Ronald Evans
Ronald Evans, PhD
Deputy Director, Translation
page link:

Ye Zheng, PhD

Professor

NOMIS Center for Immunobiology and Microbial Pathogenesis

Becky and Ralph S. O'Connor Chair

Areas of interest: molecular mechanisms of regulatory and effector T cells function

Disease models: autoimmune and metabolic diseases, tumors

Ye Zheng, PhD
Deputy Director, Education & Training
page link:

Dmitry Lyumkis, PhD

Associate Professor

Hearst Foundation Developmental Chair

Areas of interest: decoding structures of macromolecular assembly using CryoEMDisease models: cancer, inflammation

Disease models: cancer, inflammation

Dmitry Lyumkis, PhD
Deputy Director, Diversity, Equity & Inclusion
page link:

Gerald Shadel, PhD

Professor

Audrey Geisel Chair in Biomedical Science

Areas of interest: role of mitochondria in disease, aging, and immune function

Disease models: mitochondrial function in different cancers and neurodegenerative disorders

Gerald Shadel
Gerald Shadel, PhD
Deputy Director, Shared Resources
page link:

Tony Hunter, PhD

American Cancer Society Professor

Renato Dulbecco Chair

Areas of interest: phosphorylation, ubiquitylation and sumoylation in cancer

Disease models: cancer kinome, pancreatic cancer, glioblastoma, prostate cancer

Tony Hunter
Tony Hunter, PhD
Senior Advisor to the Director
page link:

Leona Flores, PhD

Leona Flores
Leona Flores, PhD
Deputy Director, Research Administration

Genome Stability, Epigenetics & Aging in Cancer Program Leaders


page link:

Diana Hargreaves, PhD

Associate Professor

Areas of interest: BAF chromatin remodeling complex and the role of chromatin regulators in cancer

Disease models: BAF subunit mutant solid tumors such as medulloblastomas

Diana Hargreaves, PhD
page link:

Jan Karlseder, PhD

Vice President, Chief Science Officer

Professor

Donald and Darlene Shiley Chair

Areas of interest: telomere function and dysregulation in cancer cells

Disease models: combined treatment of cancer with mitotic inhibitors (Taxol, Velcade and Vinblastine) and PARP inhibitors

Jan Karlseder, PhD

Tumor Immunology, Metabolism & Therapeutics Program Leaders


page link:

Janelle Ayres, PhD

Professor

Salk Institute Legacy Chair

Areas of interest: inflammation and pathobionts in the gut microbiota

Disease models: pathobionts, colorectal cancer

Janelle Ayres, PhD
page link:

Christian Metallo, PhD

Professor

Daniel and Martina Lewis Chair

Areas of interest: systems-based modeling to study metabolic regulation/flux in cells, tissues, and animals; stable isotope tracers

Disease models: cancer metabolism, metabolic syndrome and obesity, stem cell biology

Christian Metallo
Christian Metallo, PhD

Executive Committee

Executive Director, Research Operations – Julie Auger
Senior Director, Technology Development – Ha Nguyen, PhD
Interim VP, External Relations – Dan Otto
Senior Director, Research Development – David O’Keefe, PhD
Director of the Office of Diversity, Equity & Inclusion – Jálin Johnson, EdD, MBA
Chief Scientific Officer (ex officio) – Jan Karlseder, PhD
Assistant Director, Administration – Lara Avila
Administrative Assistant to the Director – Alex Dausch

External Advisory Board

Matt Vander Heiden, MD, PhD, Chair
Director, Koch Institute for Integrative Cancer Research at MIT
Associate Professor of Biology
Member, MIT Center for Precision Cancer Medicine
Member, Ludwig Center for Molecular Oncology

Steven Artandi, MD, PhD
Director, Stanford Cancer Institute
Jerome and Daisy Low Gilbert Professor of Medicine and Biochemistry

David Darr, MSc, MBA
Associate Director for Administration, UNC Lineberger Comprehensive Cancer Center

Kornelia Polyak, PhD
Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute
Co-leader, Dana-Farber Harvard Cancer Center Cancer Cell Biology Program

Yolanda Sanchez, PhD
Director & CEO, University of New Mexico Comprehensive Cancer Center
Professor, Internal Medicine, Division of Molecular Medicine

Robert Schreiber, PhD
AM Bursky & JM Bursky Distinguished Professor, Pathology & Immunology
Director, Center for Human Immunology and Immunotherapy Programs
Program Leader, Tumor Immunology, Siteman Cancer Center
Washington University School of Medicine

David Tuveson, MD, PhD
Director, Cold Spring Harbor Laboratory Cancer Center
Professor, Roy J. Zuckerberg Professor of Cancer Research

Laura J. van’t Veer, PhD
Leader, Breast Oncology Program, and Director, Applied Genomics
Angela and Shu Kai Chan Endowed Chair in Cancer Research
UCSF Helen Diller Family Comprehensive Cancer Center